CD8A and neoplasm: B lymphocytes may produce antitumor effects in different ways: they secrete specific antibodies to directly interact with tumor cells and exert humoral immunity; B cells can also act as an alternative APCs promoting CD4+ and CD8+ T cells’ response; they stimulate NK cells to directly kill tumor cells and release proinflammatory factors involved in T-cell activation [119].